Human Anti-OPGL Neutralizing Antibodies as Selective OPGL, Pathway Inhibitors

摘要

#$%^&*AU2014202309A120140522.pdf#####ABSTRACT Monoclonal antibodies and hybridomas producing them that interact with osteoprotegerin ligand (OPGL) are provided. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are also 5 provided. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are further provided.